0001209191-21-053331.txt : 20210825
0001209191-21-053331.hdr.sgml : 20210825
20210825170049
ACCESSION NUMBER: 0001209191-21-053331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210824
FILED AS OF DATE: 20210825
DATE AS OF CHANGE: 20210825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Virgin Herbert
CENTRAL INDEX KEY: 0001786378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 211207606
MAIL ADDRESS:
STREET 1: C/O VIR BIOTECHNOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-24
0
0001706431
Vir Biotechnology, Inc.
VIR
0001786378
Virgin Herbert
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO
CA
94158
0
1
0
0
EVP, Research & CSO
Common Stock
2021-08-24
4
M
0
1375
1.53
A
101075
D
Common Stock
2021-08-24
4
S
0
1375
48.00
D
99700
D
Stock Option (Right to Buy)
1.53
2021-08-24
4
M
0
1375
0.00
D
2028-01-26
Common Stock
1375
270130
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Howard Horn, Attorney-in-Fact
2021-08-25